Current Report 8-K
Champions Oncology, Inc CSBR CEO Ronnie Morris on Q4 2020 Results - YouTube
Champions Oncology: Emerging Pick And Shovel Play On Cancer Drug Development (NASDAQ:CSBR) | Seeking Alpha
championsoncologyinvesto Champions Oncology, Inc. 2020 Current Report 8-K
Ronnie Morris - Owner/opperator - RAM SECURITY & TRANSPORT. | LinkedIn
CRPC Among Cancers Targeted in Expanded Champions Line of Xenograft Models
Could The Champions Oncology, Inc. (NASDAQ:CSBR) Ownership Structure Tell Us Something Useful? | Nasdaq
Ronnie Morris's email & phone | Champions Oncology, Inc.'s President email
Leadership Team
Leadership Team
Champions Oncology, Inc. | ACCESSWIRE
Champions Oncology (NasdaqCM:CSBR) - Share price, News & Analysis - Simply Wall St
Champions Oncology - Finformer
Champions Oncology-Fannin team up to develop therapeutics for tumors | Seeking Alpha
Ronnie Morris - President - Champions Oncology, Inc. | LinkedIn
Does Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Pay Reflect Performance?
Dr. Ronnie Morris, MD – Lakeland, FL | Internal Medicine
Ronnie Morris Net Worth (2022) | wallmine
Champions Oncology, Inc. - buy, sell or hold?
Champions Oncology - Finformer
championsoncologyinvesto Champions Oncology, Inc. 2020 Current Report 8-K
Champions Oncology Company Profile: Stock Performance & Earnings | PitchBook
Champions Oncology Announces a Partnership with Fannin Innovation to Jointly Develop Therapeutic Raptamer Drug Conjugates
